[
  {
    "vaccineName": "AstraZeneca (Vaxzevria, Covishield)",
    "type": "Viral Vector",
    "targetDisease": "COVID-19",
    "vaccineTechnology": "Chimpanzee Adenovirus Vector (ChAdOx1)",
    "keyPoints": [
      "Demonstrated efficacy in preventing symptomatic COVID-19 and severe disease",
      "Administered in two doses",
      "Easier storage and transport at regular refrigerator temperatures",
      "Widely used in global vaccination efforts"
    ],
    "sideEffects": [
      "Common: Pain at the injection site, fatigue, headache, muscle pain, chills, fever, nausea",
      "Rare: Severe allergic reactions"
    ],
    "regulatoryApproval": "Received regulatory approvals in various countries and authorized for emergency use"
  },
  {
    "vaccineName": "Pfizer-BioNTech COVID-19 Vaccine",
    "type": "mRNA",
    "targetDisease": "COVID-19",
    "vaccineTechnology": "mRNA (messenger RNA)",
    "keyPoints": [
      "High efficacy in preventing symptomatic COVID-19 and severe disease",
      "Administered in two doses, typically three weeks apart",
      "Requires ultra-cold storage (-70°C or -94°F) for long-term storage",
      "Widely used in global vaccination campaigns"
    ],
    "sideEffects": [
      "Common: Pain at the injection site, fatigue, headache, muscle pain, chills, fever",
      "Rare: Allergic reactions"
    ],
    "regulatoryApproval": "Received regulatory approvals in various countries and authorized for emergency use"
  },
  {
    "vaccineName": "Sinopharm COVID-19 Vaccine",
    "type": "Inactivated Virus",
    "targetDisease": "COVID-19",
    "vaccineTechnology": "Inactivated Virus",
    "keyPoints": [
      "Developed using inactivated virus technology",
      "Demonstrated efficacy in preventing symptomatic COVID-19",
      "Administered in two doses",
      "Stable at standard refrigeration temperatures"
    ],
    "sideEffects": [
      "Common: Pain at the injection site, mild fever, fatigue",
      "Rare: Allergic reactions"
    ],
    "regulatoryApproval": "Received regulatory approvals in various countries and authorized for emergency use"
  },
  {
    "vaccineName": "Moderna COVID-19 Vaccine",
    "type": "mRNA",
    "targetDisease": "COVID-19",
    "vaccineTechnology": "mRNA (messenger RNA)",
    "keyPoints": [
      "High efficacy in preventing symptomatic COVID-19 and severe disease",
      "Administered in two doses, typically four weeks apart",
      "Requires standard freezer storage (-20°C or -4°F) for long-term storage",
      "Widely used in global vaccination efforts"
    ],
    "sideEffects": [
      "Common: Pain at the injection site, fatigue, headache, muscle pain, chills, fever",
      "Rare: Allergic reactions"
    ],
    "regulatoryApproval": "Received regulatory approvals in various countries and authorized for emergency use"
  },
  {
    "vaccineName": "Sinovac COVID-19 Vaccine",
    "type": "Inactivated Virus",
    "targetDisease": "COVID-19",
    "vaccineTechnology": "Inactivated Virus",
    "keyPoints": [
      "Developed using inactivated virus technology",
      "Administered in two doses",
      "Demonstrated efficacy in preventing symptomatic COVID-19",
      "Storage at standard refrigeration temperatures"
    ],
    "sideEffects": [
      "Common: Pain at the injection site, mild fever, fatigue",
      "Rare: Allergic reactions"
    ],
    "regulatoryApproval": "Received regulatory approvals in various countries and authorized for emergency use"
  },
  {
    "vaccineName": "Janssen COVID-19 Vaccine (Johnson & Johnson)",
    "type": "Viral Vector",
    "targetDisease": "COVID-19",
    "vaccineTechnology": "Adenovirus Vector",
    "keyPoints": [
      "Single-dose vaccine",
      "Demonstrated efficacy in preventing symptomatic COVID-19 and severe disease",
      "Storage at standard refrigeration temperatures",
      "Widely used for its convenience of a one-shot regimen"
    ],
    "sideEffects": [
      "Common: Pain at the injection site, headache, fatigue, muscle pain, fever, nausea",
      "Rare: Severe allergic reactions"
    ],
    "regulatoryApproval": "Received regulatory approvals in various countries and authorized for emergency use"
  },
  {
    "vaccineName": "Comirnaty (Pfizer-BioNTech COVID-19 Vaccine)",
    "type": "mRNA",
    "targetDisease": "COVID-19",
    "vaccineTechnology": "mRNA (messenger RNA)",
    "keyPoints": [
      "High efficacy in preventing symptomatic COVID-19 and severe disease",
      "Administered in two doses, typically three weeks apart",
      "Requires ultra-cold storage (-70°C or -94°F) for long-term storage",
      "Widely used in global vaccination efforts"
    ],
    "sideEffects": [
      "Common: Pain at the injection site, fatigue, headache, muscle pain, chills, fever",
      "Rare: Allergic reactions"
    ],
    "regulatoryApproval": "Received regulatory approvals in various countries and authorized for emergency use"
  }
]
